From best evidence to best practice — what are the obstacles?

This publication has 32 references indexed in Scilit:

• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Cardiac rehabilitation
  European Heart Journal, 1998
• The Treatment Gap in Coronary Artery Disease and Heart Failure: Community Standards and the Post-Discharge Patient
  The American Journal of Cardiology, 1997
• International comparison of awareness and attitudes towards coronary risk factor reduction: the HELP study
  Journal of Cardiovascular Risk, 1997
• Effects of Outreach Visits by Trained Nurses on Cardiovascular Risk-Factor Recording in General Practice
  The European Journal of General Practice, 1997
• Prevention of Coronary Heart Disease in Clinical Practice: A Commentary on Current Treatment Patterns in Six European Countries in Relation to Published Recommendations
  Cardiology, 1996
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
  The Lancet, 1994
• Recall of recommendations and adherence to advice among patients with chronic medical conditions
  Archives of internal medicine (1960), 1993
• β-Blockers: Primary and Secondary Prevention
  Journal of Cardiovascular Pharmacology, 1992
• Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction
  Published by American Medical Association (AMA) ,1988